Genetic variation of the PSCA gene (rs2294008) is not associated with the risk of prostate cancer

Abstract

Prostate stem cell antigen (PSCA) is a cell-membrane glycoprotein consisting of 123 amino acids and highly expressed in the prostate, but there have been few reports on the relationship between rs2294008 ofPSCA and prostate cancer in the literature. Therefore, we evaluated the association between rs2294008 and the risk of prostate cancer. A total of 240 prostate cancer patients and 306 controls (patients with benign prostatic hyperplasia) were enrolled. Genotype analysis of rs2294008 ofPSCA was performed using PCR. Logistic regression analysis was performed according to the genotype ofPSCA rs2294008. We found that CT and TT genotypes were associated with an insignificant risk of prostate cancer compared with the CC genotype (P= 0.627 and 0.397, respectively). In addition, there was no significant difference in rs2294008 according to clinicopathological parameters, such as age, Gleason score, prostate-specific antigen (PSA), stage, and metastasis in prostate cancer (P>0.05 for each). Age, Gleason score, PSA, pathologic stage, and metastasis did not modify the association between PSCA and the risk of prostate cancer (each P>0.05 for each). Taken together, the genetic polymorphism of PSCA rs2294008 was not associated with the risk of prostate cancer. Our results suggest that rs2294008 may not play a role in prostate carcinogenesis.

Keywords

prostatic neoplasms / polymorphism / genetic / risk / prostate / polymorphism / single nucleotide

References

[1] Howlader NNA, Krapcho  M, Miller D , SEER Cancer Statistics Factsheets: Prostate Cancer[EB/OL]. National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/statfacts/html/prost.html

[2] Struewing JP, Hartge  P, Wacholder S , The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews[J]. N Engl J Med, 1997, 336(20): 1401–1408

[3] Tomlins SA, Laxman  B, Varambally S , Role of the TMPRSS2-ERG gene fusion in prostate cancer[J]. Neoplasia, 2008, 10(2): 177–188

[4] Zheng SL, Sun  J, Wiklund F , Cumulative association of five genetic variants with prostate cancer[J]. N Engl J Med, 2008, 358(9): 910–919

[5] Gudmundsson J, Sulem  P, Manolescu A , Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24[J]. Nat Genet, 2007, 39(5): 631–637

[6] Yeager M, Orr  N, Hayes RB , Genome-wide association study of prostate cancer identifies a second risk locus at 8q24[J]. Nat Genet, 2007, 39(5): 645–649

[7] Thomas G, Jacobs  KB, Yeager M , Multiple loci identified in a genome-wide association study of prostate cancer[J]. Nat Genet, 2008, 40(3): 310–315

[8] Gu Z, Thomas  G, Yamashiro J , Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer[J]. Oncogene, 2000, 19(10): 1288–1296

[9] Amara N, Palapattu  GS, Schrage M , Prostate stem cell antigen is overexpressed in human transitional cell carcinoma[J]. Cancer Res, 2001, 61(12): 4660–4665

[10] Joung JY, Lee  YS, Park S , Haplotype analysis of prostate stem cell antigen and association with prostate cancer risk[J]. J Urol, 2011, 185(6): 2112–2118

[11] Gu Z, Yamashiro  J, Kono E , Anti-prostate stem cell antigen monoclonal antibody 1G8 induces cell death in vitro and inhibits tumor growth in vivo via a Fc-independent mechanism[J]. Cancer Res, 2005, 65(20): 9495–9500

[12] Argani P, Rosty  C, Reiter RE , Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma[J]. Cancer Res, 2001, 61(11): 4320–4324

[13] Bahrenberg G, Brauers  A, Joost HG , Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors[J]. Biochem Biophys Res Commun, 2000, 275(3): 783–788

[14] de Nooij-van Dalen AG ,  van Dongen GA ,  Smeets SJ , Characterization of the human Ly-6 antigens, the newly annotated member Ly-6K included, as molecular markers for head-and-neck squamous cell carcinoma[J]. Int J Cancer, 2003, 103(6): 768–774

[15] Song HR, Kim  HN, Piao JM , Association of a common genetic variant in prostate stem-cell antigen with gastric cancer susceptibility in a Korean population[J]. Mol Carcinog, 2011, 50(11): 871–875

[16] Lu Y, Chen  J, Ding Y , Genetic variation of PSCA gene is associated with the risk of both diffuse- and intestinal-type gastric cancer in a Chinese population[J]. Int J Cancer, 2010, 127(9): 2183–2189

[17] Yates DR, Rouprêt  M, Drouin SJ , Genetic polymorphisms on 8q24.1 and 4p16.3 are not linked with urothelial carcinoma of the bladder in contrast to their association with aggressive upper  urinary tract  tumours[J].  World  J  Urol, 2013, 31(1): 53–59

[18] Fu YP, Kohaar  I, Rothman N , Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk[J]. Proc Natl Acad Sci U S A, 2012, 109(13): 4974–4979

Acknowledgements

This work was supported by the research grant of Chungbuk National University in 2014.

RIGHTS & PERMISSIONS

2017 2017 by the Journal of Biomedical Research. All rights reserved.